PURE BIOSCIENCE, INC. Quarterly Return On Equity in % from Q1 2012 to Q1 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Pure Bioscience, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q1 2024.
  • Pure Bioscience, Inc. Return On Equity for the quarter ending April 30, 2024 was 405 %.
  • Pure Bioscience, Inc. annual Return On Equity for 2023 was -240 %, a 79.1% decline from 2022.
  • Pure Bioscience, Inc. annual Return On Equity for 2022 was -134 %, a 140% decline from 2021.
  • Pure Bioscience, Inc. annual Return On Equity for 2021 was -55.9 %, a 35829% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 405 +568 Feb 1, 2024 Apr 30, 2024
Q4 2023 8.24K +8.39K Nov 1, 2023 Jan 31, 2024
Q3 2023 -461 -323 -234% Aug 1, 2023 Oct 31, 2023
Q2 2023 -240 -106 -79.1% May 1, 2023 Jul 31, 2023
Q1 2023 -163 -41.1 -33.7% Feb 1, 2023 Apr 30, 2023
Q4 2022 -153 -53.5 -53.6% Nov 1, 2022 Jan 31, 2023
Q3 2022 -138 -57 -70.3% Aug 1, 2022 Oct 31, 2022
Q2 2022 -134 -78.3 -140% May 1, 2022 Jul 31, 2022
Q1 2022 -122 -116 -1984% Feb 1, 2022 Apr 30, 2022
Q4 2021 -100 -123 -528% Nov 1, 2021 Jan 31, 2022
Q3 2021 -81.1 -109 -394% Aug 1, 2021 Oct 31, 2021
Q2 2021 -55.9 -56 -35829% May 1, 2021 Jul 31, 2021
Q1 2021 -5.84 +123 +95.5% Feb 1, 2021 Apr 30, 2021
Q4 2020 23.4 +422 Nov 1, 2020 Jan 31, 2021
Q3 2020 27.6 +450 Aug 1, 2020 Oct 31, 2020
Q2 2020 0.16 +482 May 1, 2020 Jul 31, 2020
Q1 2020 -129 +385 +74.9% Feb 1, 2020 Apr 30, 2020
Q4 2019 -399 +27.3 +6.42% Nov 1, 2019 Jan 31, 2020
Q3 2019 -423 -68.9 -19.5% Aug 1, 2019 Oct 31, 2019
Q2 2019 -482 -218 -82.5% May 1, 2019 Jul 31, 2019
Q1 2019 -515 -234 -83.7% Feb 1, 2019 Apr 30, 2019
Q4 2018 -426 -151 -55.2% Nov 1, 2018 Jan 31, 2019
Q3 2018 -354 -129 -57.5% Aug 1, 2018 Oct 31, 2018
Q2 2018 -264 -40.6 -18.2% May 1, 2018 Jul 31, 2018
Q1 2018 -280 -144 -105% Feb 1, 2018 Apr 30, 2018
Q4 2017 -274 -135 -96.8% Nov 1, 2017 Jan 31, 2018
Q3 2017 -225 -1.47K -118% Aug 1, 2017 Oct 31, 2017
Q2 2017 -223 -981 -129% May 1, 2017 Jul 31, 2017
Q1 2017 -136 -745 -122% Feb 1, 2017 Apr 30, 2017
Q4 2016 -139 -1.96K -108% Nov 1, 2016 Jan 31, 2017
Q3 2016 1.25K +1.56K Aug 1, 2016 Oct 31, 2016
Q2 2016 758 +940 May 1, 2016 Jul 31, 2016
Q1 2016 609 +844 Feb 1, 2016 Apr 30, 2016
Q4 2015 1.82K +2.1K Nov 1, 2015 Jan 31, 2016
Q3 2015 -317 +118 +27.2% Aug 1, 2015 Oct 31, 2015
Q2 2015 -182 +1.65K +90% May 1, 2015 Jul 31, 2015
Q1 2015 -235 +2.76K +92.2% Feb 1, 2015 Apr 30, 2015
Q4 2014 -274 +3.67K +93.1% Nov 1, 2014 Jan 31, 2015
Q3 2014 -435 +1.57K +78.3% Aug 1, 2014 Oct 31, 2014
Q2 2014 -1.83K -1.18K -183% May 1, 2014 Jul 31, 2014
Q1 2014 -3K -2.51K -512% Feb 1, 2014 Apr 30, 2014
Q4 2013 -3.94K -3.5K -779% Nov 1, 2013 Jan 31, 2014
Q3 2013 -2K -1.57K -363% Aug 1, 2013 Oct 31, 2013
Q2 2013 -648 -202 -45.3% May 1, 2013 Jul 31, 2013
Q1 2013 -490 -194 -65.5% Feb 1, 2013 Apr 30, 2013
Q4 2012 -449 Nov 1, 2012 Jan 31, 2013
Q3 2012 -433 Aug 1, 2012 Oct 31, 2012
Q2 2012 -446 May 1, 2012 Jul 31, 2012
Q1 2012 -296 Feb 1, 2012 Apr 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.